Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Johnson and Johnson
Mallinckrodt
Boehringer Ingelheim
Accenture
Cipla
Express Scripts
Harvard Business School
Teva

Generated: April 21, 2018

DrugPatentWatch Database Preview

SALUTENSIN Drug Profile

« Back to Dashboard

When do Salutensin patents expire, and when can generic versions of Salutensin launch?

Salutensin is a drug marketed by Shire and is included in one NDA.

The generic ingredient in SALUTENSIN is hydroflumethiazide; reserpine. There are two drug master file entries for this compound. Additional details are available on the hydroflumethiazide; reserpine profile page.
Summary for SALUTENSIN
Drug patent expirations by year for SALUTENSIN

US Patents and Regulatory Information for SALUTENSIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Shire SALUTENSIN hydroflumethiazide; reserpine TABLET;ORAL 012359-003 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Shire SALUTENSIN-DEMI hydroflumethiazide; reserpine TABLET;ORAL 012359-004 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
Baxter
Argus Health
Medtronic
Queensland Health
Healthtrust
Deloitte
Teva
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.